Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-011079

Chief Executive Officer gave up 1,972 shares (to pay taxes)

  • Chief Executive Officer acquired 6,732 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robinson Chandler Chief Executive Officer 2026-03-31 Option exercise +6,732 92,450 D
Robinson Chandler Chief Executive Officer 2026-03-31 Shares withheld for taxes −1,972 $54.79 $108,046 90,478 D
Derivatives
Robinson Chandler Chief Executive Officer 2026-03-31 Option exercise · Restricted Stock Unit −6,732 106,276 D
Loading xslF345X06/rdgdoc.xml…